
Ceftes SL 500mg/250mg Injection
Marketer
Tesni Pharmaceuticals
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Ceftes SL 500mg/250mg Injection
Combiflox 500mg/250mg injection is a dual-action antibiotic indicated for treating diverse bacterial infections. Its mechanism combats microbial proliferation, halting infection spread. Administration should strictly follow a healthcare provider's guidance; missed doses should be avoided, and the prescribed treatment course must be completed regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt emergency care. Prior to commencing treatment, disclose all current medications and health conditions to your physician. Pregnant or lactating individuals must consult their doctor before use. Alcohol consumption is contraindicated due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your physician may order laboratory tests to monitor treatment response.
Primary Ingredients of Ceftes SL 500mg/250mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Ceftes SL 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Ceftes SL 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ceftes SL 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftes SL 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ceftes SL 500mg/250mg Injection works:
Ceftes SL injection, containing 500mg Ceftriaxone and 250mg Sulbactam, utilizes a dual-action mechanism. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ceftes SL 500mg/250mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftes SL, in 500mg/250mg doses, is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Ceftes SL 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceftes SL 500mg/250mg Injection might reduce awareness, impair visual acuity, and induce drowsiness or dizziness. Driving is prohibited if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceftes SL 500mg/250mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Exercise caution when administering Ceftes SL 500mg/250mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alteration for Ceftes SL 500mg/250mg Injection is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Ceftes SL 500mg/250mg Injection :
Should you forget a scheduled Ceftes SL 500mg/250mg Injection, seek immediate medical advice.
Facts to Know About Ceftes SL 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
